{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:16:49Z","timestamp":1788304609137,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":57,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_16","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:49:59Z","timestamp":1788302999000},"page":"261-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Biotinylated Red Blood Cells Following Transfusion"],"prefix":"10.1007","author":[{"given":"Mischa L.","family":"Covington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Zerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samata P.","family":"Varadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Roback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross M.","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne E. M.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"1","key":"16_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01237-z","volume":"15","author":"AM Brandow","year":"2022","unstructured":"Brandow AM, Liem RI (2022) Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol 15(1):20. https:\/\/doi.org\/10.1186\/s13045-022-01237-z. Epub 20220303. PubMed PMID: 35241123; PubMed Central PMCID: PMCPMC8895633","journal-title":"J Hematol Oncol"},{"issue":"1","key":"16_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2022.10233","volume":"328","author":"PL Kavanagh","year":"2022","unstructured":"Kavanagh PL, Fasipe TA, Wun T (2022) Sickle cell disease: a review. JAMA 328(1):57\u201368. https:\/\/doi.org\/10.1001\/jama.2022.10233","journal-title":"JAMA"},{"issue":"1","key":"16_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajh.24235","volume":"91","author":"S Chaturvedi","year":"2016","unstructured":"Chaturvedi S, DeBaun MR (2016) Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years. Am J Hematol 91(1):5\u201314. https:\/\/doi.org\/10.1002\/ajh.24235","journal-title":"Am J Hematol"},{"issue":"4","key":"16_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","volume":"189","author":"J Ansari","year":"2019","unstructured":"Ansari J, Gavins FNE (2019) Ischemia-reperfusion injury in sickle cell disease: from basics to therapeutics. Am J Pathol 189(4):706\u2013718. https:\/\/doi.org\/10.1016\/j.ajpath.2018.12.012. PubMed PMID: 30904156; PubMed Central PMCID: PMCPMC6446225","journal-title":"Am J Pathol"},{"issue":"8","key":"16_CR5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","volume":"127","author":"G Dumas","year":"2016","unstructured":"Dumas G, Habibi A, Onimus T, Merle JC, Razazi K, Mekontso Dessap A et al (2016) Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients. Blood 127(8):1062\u20131064. https:\/\/doi.org\/10.1182\/blood-2015-09-669770. Epub 20160112. PubMed PMID: 26758914","journal-title":"Blood"},{"issue":"4","key":"16_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104205","volume":"52","author":"MS Meuleman","year":"2023","unstructured":"Meuleman MS, Roumenina LT, Grunenwald A (2023) Complement involvement in sickle cell disease. Presse Med 52(4):104205. https:\/\/doi.org\/10.1016\/j.lpm.2023.104205. Epub 20231114. PubMed PMID: 37972851","journal-title":"Presse Med"},{"issue":"2","key":"16_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tracli.2019.02.008","volume":"26","author":"NS Merle","year":"2019","unstructured":"Merle NS, Boudhabhay I, Leon J, Fremeaux-Bacchi V, Roumenina LT (2019) Complement activation during intravascular hemolysis: implication for sickle cell disease and hemolytic transfusion reactions. Transfus Clin Biol. 26(2):116\u2013124. https:\/\/doi.org\/10.1016\/j.tracli.2019.02.008. Epub 20190222. PubMed PMID: 30879901","journal-title":"Transfus Clin Biol."},{"issue":"13","key":"16_CR8","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1073\/pnas.1814797116","volume":"116","author":"NS Merle","year":"2019","unstructured":"Merle NS, Paule R, Leon J, Daugan M, Robe-Rybkine T, Poillerat V et al (2019) P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4\/heme-dependent manner. Proc Natl Acad Sci U S A. 116(13):6280\u20136285. https:\/\/doi.org\/10.1073\/pnas.1814797116. Epub 20190308. PubMed PMID: 30850533; PubMed Central PMCID: PMCPMC6442544","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"16_CR9","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.3324\/haematol.2020.262006","volume":"105","author":"S Chonat","year":"2020","unstructured":"Chonat S, Graciaa S, Shin HS, Newton JG, Quarmyne MO, Boudreaux J et al (2020) Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease. Haematologica. 105(12):2887\u20132891. https:\/\/doi.org\/10.3324\/haematol.2020.262006. Epub 20201201. PubMed PMID: 33256394; PubMed Central PMCID: PMCPMC7716365","journal-title":"Haematologica."},{"issue":"10","key":"16_CR10","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","volume":"103","author":"S Chonat","year":"2018","unstructured":"Chonat S, Quarmyne MO, Bennett CM, Dean CL, Joiner CH, Fasano RM et al (2018) Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease. Haematologica. 103(10):e483\u2013e4e5. https:\/\/doi.org\/10.3324\/haematol.2018.194670. Epub 20180524. PubMed PMID: 29794144; PubMed Central PMCID: PMCPMC6165824","journal-title":"Haematologica."},{"issue":"11","key":"16_CR11","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1172\/JCI64578","volume":"123","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Adisa OA, Chappa P, Tan F, Jackson KA, Archer DR et al (2013) Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J Clin Invest 123(11):4809\u20134820. https:\/\/doi.org\/10.1172\/JCI64578. PubMed PMID: 24084741; PubMed Central PMCID: PMCPMC3809772","journal-title":"J Clin Invest"},{"issue":"1","key":"16_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/asheducation-2016.1.625","volume":"2016","author":"J Howard","year":"2016","unstructured":"Howard J (2016) Sickle cell disease: when and how to transfuse. Hematol Am Soc Hematol Educ Program 2016(1):625\u2013631. https:\/\/doi.org\/10.1182\/asheducation-2016.1.625. PubMed PMID: 27913538; PubMed Central PMCID: PMCPMC6142434","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"9","key":"16_CR13","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/trf.17966","volume":"64","author":"E Viayna","year":"2024","unstructured":"Viayna E, Gehrie EA, Blanchette C (2024) Alloimmunization in myelodysplastic syndrome is associated with higher healthcare costs, longer hospitalizations, and increased mortality. Transfusion 64(9):1640\u20131647. https:\/\/doi.org\/10.1111\/trf.17966. Epub 20240807. PubMed PMID: 39109551","journal-title":"Transfusion"},{"issue":"20","key":"16_CR14","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1182\/bloodadvances.2022006982","volume":"6","author":"E Viayna","year":"2022","unstructured":"Viayna E, Gehrie EA, Blanchette C, Meny GM, Noumsi G, Huber M et al (2022) Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality. Blood Adv 6(20):5655\u20135658. https:\/\/doi.org\/10.1182\/bloodadvances.2022006982. PubMed PMID: 35939787; PubMed Central PMCID: PMCPMC9582716","journal-title":"Blood Adv"},{"issue":"6 Pt 2","key":"16_CR15","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/trf.12940","volume":"55","author":"MJ Telen","year":"2015","unstructured":"Telen MJ, Afenyi-Annan A, Garrett ME, Combs MR, Orringer EP, Ashley-Koch AE (2015) Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion. 55(6 Pt 2):1378\u20131387. https:\/\/doi.org\/10.1111\/trf.12940. Epub 20141201. PubMed PMID: 25444611; PubMed Central PMCID: PMCPMC4451450","journal-title":"Transfusion."},{"issue":"1","key":"16_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/trf.13379","volume":"56","author":"RS Nickel","year":"2016","unstructured":"Nickel RS, Hendrickson JE, Fasano RM, Meyer EK, Winkler AM, Yee MM et al (2016) Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Transfusion. 56(1):107\u2013114. https:\/\/doi.org\/10.1111\/trf.13379. Epub 20151028. PubMed PMID: 26509333","journal-title":"Transfusion."},{"issue":"3","key":"16_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3324\/haematol.2019.224709","volume":"105","author":"SL Thein","year":"2020","unstructured":"Thein SL, Pirenne F, Fasano RM, Habibi A, Bartolucci P, Chonat S et al (2020) Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal. Haematologica. 105(3):539\u2013544. https:\/\/doi.org\/10.3324\/haematol.2019.224709. Epub 20200206. PubMed PMID: 32029505; PubMed Central PMCID: PMCPMC7049330","journal-title":"Haematologica."},{"issue":"12","key":"16_CR18","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/ajh.24908","volume":"92","author":"D Narbey","year":"2017","unstructured":"Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelievre JD et al (2017) Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease. Am J Hematol 92(12):1340\u20131348. Epub 20171031. https:\/\/doi.org\/10.1002\/ajh.24908","journal-title":"Am J Hematol"},{"issue":"4","key":"16_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.4049\/jimmunol.2100784","volume":"208","author":"A Soldatenko","year":"2022","unstructured":"Soldatenko A, Hoyt LR, Xu L, Calabro S, Lewis SM, Gallman AE et al (2022) Innate and adaptive immunity to transfused allogeneic RBCs in mice requires myD88. J Immunol. 208(4):991\u2013997. https:\/\/doi.org\/10.4049\/jimmunol.2100784. Epub 20220117. PubMed PMID: 35039331; PubMed Central PMCID: PMCPMC10107373","journal-title":"J Immunol."},{"issue":"11","key":"16_CR20","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.3324\/haematol.2016.149278","volume":"101","author":"A Arneja","year":"2016","unstructured":"Arneja A, Salazar JE, Jiang W, Hendrickson JE, Zimring JC, Luckey CJ (2016) Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization. Haematologica. 101(11):e440\u2013e4e4. https:\/\/doi.org\/10.3324\/haematol.2016.149278. Epub 20160804. PubMed PMID: 27662015; PubMed Central PMCID: PMCPMC5394864","journal-title":"Haematologica."},{"key":"16_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629608","volume":"12","author":"A Jash","year":"2021","unstructured":"Jash A, Usaneerungrueng C, Howie HL, Qiu A, Luckey CJ, Zimring JC et al (2021) Antibodies to low-copy number RBC alloantigen convert a tolerogenic stimulus to an immunogenic stimulus in mice. Front Immunol. 12:629608. https:\/\/doi.org\/10.3389\/fimmu.2021.629608. Epub 20210312. PubMed PMID: 33777014; PubMed Central PMCID: PMCPMC7994621","journal-title":"Front Immunol."},{"key":"16_CR22","doi-asserted-by":"publisher","unstructured":"Jash A, Pridmore T, Collins JB, Hay AM, Hudson KE, Luckey CJ et al (2024) Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. J Clin Invest. 134(8). https:\/\/doi.org\/10.1172\/JCI167665. Epub 20240415. PubMed PMID: 38618959; PubMed Central PMCID: PMCPMC11014669","DOI":"10.1172\/JCI167665"},{"key":"16_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01516","volume":"11","author":"P Shinde","year":"2020","unstructured":"Shinde P, Howie HL, Stegmann TC, Hay AM, Waterman HR, Szittner Z et al (2020) IgG subclass determines suppression versus enhancement of humoral alloimmunity to kell RBC antigens in mice. Front Immunol. 11:1516. https:\/\/doi.org\/10.3389\/fimmu.2020.01516. Epub 20200716. PubMed PMID: 32765523; PubMed Central PMCID: PMCPMC7378678","journal-title":"Front Immunol."},{"key":"16_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.704072","volume":"12","author":"V Escamilla-Rivera","year":"2021","unstructured":"Escamilla-Rivera V, Santhanakrishnan M, Liu J, Gibb DR, Forsmo JE, Foxman EF et al (2021) Complement plays a critical role in inflammation-induced immunoprophylaxis failure in mice. Front Immunol. 12:704072. https:\/\/doi.org\/10.3389\/fimmu.2021.704072. Epub 20210625. PubMed PMID: 34249009; PubMed Central PMCID: PMCPMC8270673","journal-title":"Front Immunol."},{"key":"16_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1475470","volume":"15","author":"RP Jajosky","year":"2024","unstructured":"Jajosky RP, Ayona D, Mener A, Stowell SR, Arthur CM (2024) Dynamics of antibody engagement of red blood cells in vivo and in vitro. Front Immunol. 15:1475470. https:\/\/doi.org\/10.3389\/fimmu.2024.1475470. Epub 20241128. PubMed PMID: 39669570; PubMed Central PMCID: PMCPMC11634868","journal-title":"Front Immunol."},{"issue":"8","key":"16_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood.2020009376","volume":"138","author":"PE Zerra","year":"2021","unstructured":"Zerra PE, Patel SR, Jajosky RP, Arthur CM, McCoy JW, Allen JWL et al (2021) Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice. Blood 138(8):706\u2013721. https:\/\/doi.org\/10.1182\/blood.2020009376. PubMed PMID: 33876205; PubMed Central PMCID: PMCPMC8394907","journal-title":"Blood"},{"key":"16_CR27","doi-asserted-by":"publisher","unstructured":"Mener A, Patel SR, Arthur CM, Chonat S, Wieland A, Santhanakrishnan M et al (2018) Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses. JCI Insight 3(22). https:\/\/doi.org\/10.1172\/jci.insight.121631. Epub 20181115. PubMed PMID: 30429364; PubMed Central PMCID: PMCPMC6302935","DOI":"10.1172\/jci.insight.121631"},{"issue":"7","key":"16_CR28","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.4049\/jimmunol.1601736","volume":"198","author":"CM Arthur","year":"2017","unstructured":"Arthur CM, Patel SR, Smith NH, Bennett A, Kamili NA, Mener A et al (2017) Antigen density dictates immune responsiveness following red blood cell transfusion. J Immunol. 198(7):2671\u20132680. https:\/\/doi.org\/10.4049\/jimmunol.1601736. Epub 20170301. PubMed PMID: 28250159; PubMed Central PMCID: PMCPMC5777137","journal-title":"J Immunol."},{"key":"16_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02516","volume":"9","author":"SR Patel","year":"2018","unstructured":"Patel SR, Gibb DR, Girard-Pierce K, Zhou X, Rodrigues LC, Arthur CM et al (2018) Marginal zone B cells induce alloantibody formation following RBC transfusion. Front Immunol. 9:2516. https:\/\/doi.org\/10.3389\/fimmu.2018.02516. Epub 20181116. PubMed PMID: 30505302; PubMed Central PMCID: PMCPMC6250814","journal-title":"Front Immunol."},{"issue":"12","key":"16_CR30","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood.2022018591","volume":"142","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP, Patel KR, Allen JWL, Zerra PE, Chonat S, Ayona D et al (2023) Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood 142(12):1082\u20131098. https:\/\/doi.org\/10.1182\/blood.2022018591. PubMed PMID: 37363865; PubMed Central PMCID: PMCPMC10541552","journal-title":"Blood"},{"key":"16_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1548548","volume":"16","author":"RP Jajosky","year":"2025","unstructured":"Jajosky RP, Covington ML, Liu J, Chai L, Zerra PE, Chonat S et al (2025) CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion. Front Immunol. 16:1548548. https:\/\/doi.org\/10.3389\/fimmu.2025.1548548. Epub 20250404. PubMed PMID: 40255405; PubMed Central PMCID: PMCPMC12006802","journal-title":"Front Immunol."},{"issue":"807","key":"16_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl4922","volume":"17","author":"S Chonat","year":"2025","unstructured":"Chonat S, Jones JA, Patel SR, Briones WM, Schoettler ML, Maarouf M et al (2025) Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target. Sci Transl Med 17(807):eadl4922. https:\/\/doi.org\/10.1126\/scitranslmed.adl4922. Epub 20250716. PubMed PMID: 40668893","journal-title":"Sci Transl Med"},{"issue":"3","key":"16_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/trf.17251","volume":"63","author":"CL Maier","year":"2023","unstructured":"Maier CL, Jajosky RP, Patel SR, Verkerke HP, Fuller MD, Allen JW et al (2023) Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice. Transfusion. 63(3):457\u2013462. https:\/\/doi.org\/10.1111\/trf.17251. Epub 20230127. PubMed PMID: 36708051; PubMed Central PMCID: PMCPMC10414794","journal-title":"Transfusion."},{"issue":"6","key":"16_CR34","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1182\/blood-2008-03-146415","volume":"112","author":"JM Higgins","year":"2008","unstructured":"Higgins JM, Sloan SR (2008) Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood. 112(6):2546\u20132553. https:\/\/doi.org\/10.1182\/blood-2008-03-146415. Epub 20080605. PubMed PMID: 18535200","journal-title":"Blood."},{"issue":"21","key":"16_CR35","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1182\/blood.2022016588","volume":"141","author":"R Jajosky","year":"2023","unstructured":"Jajosky R, Patel SR, Wu SC, Patel K, Covington M, Vallecillo-Zuniga M et al (2023) Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice. Blood 141(21):2642\u20132653. https:\/\/doi.org\/10.1182\/blood.2022016588. PubMed PMID: 36638335; PubMed Central PMCID: PMCPMC10356576","journal-title":"Blood"},{"issue":"23","key":"16_CR36","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","volume":"130","author":"PE Zerra","year":"2017","unstructured":"Zerra PE, Cox C, Baldwin WH, Patel SR, Arthur CM, Lollar P et al (2017) Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A. Blood. 130(23):2559\u20132568. https:\/\/doi.org\/10.1182\/blood-2017-05-782912. Epub 20171004. PubMed PMID: 28978569; PubMed Central PMCID: PMCPMC5721282","journal-title":"Blood."},{"issue":"9","key":"16_CR37","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.2020009210","volume":"139","author":"CM Arthur","year":"2022","unstructured":"Arthur CM, Zerra PE, Shin S, Wang J, Song X, Doering CB et al (2022) Nonhuman glycans can regulate anti-factor VIII antibody formation in mice. Blood 139(9):1312\u20131317. https:\/\/doi.org\/10.1182\/blood.2020009210. PubMed PMID: 34019619; PubMed Central PMCID: PMCPMC8900271","journal-title":"Blood"},{"issue":"14","key":"16_CR38","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2015-10-673426","volume":"127","author":"CM Arthur","year":"2016","unstructured":"Arthur CM, Patel SR, Sullivan HC, Winkler AM, Tormey CA, Hendrickson JE et al (2016) CD8+ T cells mediate antibody-independent platelet clearance in mice. Blood. 127(14):1823\u20131827. https:\/\/doi.org\/10.1182\/blood-2015-10-673426. Epub 20160119. PubMed PMID: 26787734; PubMed Central PMCID: PMCPMC4825415","journal-title":"Blood."},{"key":"16_CR39","doi-asserted-by":"publisher","unstructured":"Li C, Piran S, Chen P, Lang S, Zarpellon A, Jin JW, et al. The maternal immune response to fetal platelet GPIbalpha causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. J Clin Invest. 2011;121(11):4537\u20134547. doi:https:\/\/doi.org\/10.1172\/JCI57850. Epub 20111024. PubMed PMID: 22019589; PubMed Central PMCID: PMCPMC3204841","DOI":"10.1172\/JCI57850"},{"issue":"18","key":"16_CR40","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","volume":"116","author":"P Chen","year":"2010","unstructured":"Chen P, Li C, Lang S, Zhu G, Reheman A, Spring CM et al (2010) Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood. 116(18):3660\u20133668. https:\/\/doi.org\/10.1182\/blood-2010-05-284919. Epub 20100720. PubMed PMID: 20647570","journal-title":"Blood."},{"issue":"18","key":"16_CR41","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1182\/blood.2021011131","volume":"138","author":"X Xu","year":"2021","unstructured":"Xu X, Chen D, Ye X, Xia W, Xu Y, Chen Y et al (2021) Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model. Blood 138(18):1757\u20131767. https:\/\/doi.org\/10.1182\/blood.2021011131. PubMed PMID: 34041523; PubMed Central PMCID: PMCPMC8701625","journal-title":"Blood"},{"issue":"2","key":"16_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.gendis.2015.02.003","volume":"2","author":"B Vadasz","year":"2015","unstructured":"Vadasz B, Chen P, Yougbare I, Zdravic D, Li J, Li C et al (2015) Platelets and platelet alloantigens: lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia. Genes Dis 2(2):173\u2013185. https:\/\/doi.org\/10.1016\/j.gendis.2015.02.003. PubMed PMID: 28345015; PubMed Central PMCID: PMCPMC5362271","journal-title":"Genes Dis"},{"issue":"6","key":"16_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111172","volume":"85","author":"DK Newman","year":"2024","unstructured":"Newman DK, Newman PJ (2024) Antigen-specific immunotherapy for platelet alloimmune disorders. Hum Immunol 85(6):111172. https:\/\/doi.org\/10.1016\/j.humimm.2024.111172. Epub 20241108. PubMed PMID: 39520801; PubMed Central PMCID: PMCPMC11637901","journal-title":"Hum Immunol"},{"issue":"20","key":"16_CR44","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1182\/blood.2022015666","volume":"140","author":"H Zhi","year":"2022","unstructured":"Zhi H, Sheridan D, Newman DK, Newman PJ (2022) Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice. Blood 140(20):2146\u20132153. https:\/\/doi.org\/10.1182\/blood.2022015666. PubMed PMID: 35881848; PubMed Central PMCID: PMCPMC9837438","journal-title":"Blood"},{"issue":"18","key":"16_CR45","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/bloodadvances.2021004371","volume":"5","author":"H Zhi","year":"2021","unstructured":"Zhi H, Ahlen MT, Skogen B, Newman DK, Newman PJ (2021) Preclinical evaluation of immunotherapeutic regimens for fetal\/neonatal alloimmune thrombocytopenia. Blood Adv 5(18):3552\u20133562. https:\/\/doi.org\/10.1182\/bloodadvances.2021004371. PubMed PMID: 34470046; PubMed Central PMCID: PMCPMC8945581","journal-title":"Blood Adv"},{"issue":"17","key":"16_CR46","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","volume":"133","author":"CA Tormey","year":"2019","unstructured":"Tormey CA, Hendrickson JE (2019) Transfusion-related red blood cell alloantibodies: induction and consequences. Blood. 133(17):1821\u20131830. https:\/\/doi.org\/10.1182\/blood-2018-08-833962. Epub 20190226. PubMed PMID: 30808636; PubMed Central PMCID: PMCPMC6484385","journal-title":"Blood."},{"issue":"6","key":"16_CR47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MOH.0000000000000462","volume":"25","author":"AJ Siddon","year":"2018","unstructured":"Siddon AJ, Kenney BC, Hendrickson JE, Tormey CA (2018) Delayed haemolytic and serologic transfusion reactions: pathophysiology, treatment and prevention. Curr Opin Hematol 25(6):459\u2013467. https:\/\/doi.org\/10.1097\/MOH.0000000000000462. PubMed PMID: 30124474","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"16_CR48","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1111\/trf.13704","volume":"56","author":"G Stack","year":"2016","unstructured":"Stack G, Tormey CA (2016) Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence. Transfusion 56(11):2662\u20132667. https:\/\/doi.org\/10.1111\/trf.13704. Epub 20160709. PubMed PMID: 27394029","journal-title":"Transfusion"},{"issue":"8","key":"16_CR49","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/trf.16967","volume":"62","author":"ML Covington","year":"2022","unstructured":"Covington ML, Cone-Sullivan JK, Andrzejewski C, Lu W, Thomasson RR, O\u2019Brien K et al (2022) Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: challenges and opportunities for improvement. Transfusion 62(8):1662\u20131670. https:\/\/doi.org\/10.1111\/trf.16967. PubMed PMID: 35778994. Epub 20220702","journal-title":"Transfusion"},{"issue":"5","key":"16_CR50","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1111\/trf.15227","volume":"59","author":"CL Dean","year":"2019","unstructured":"Dean CL, Maier CL, Chonat S, Chang A, Carden MA, El Rassi F et al (2019) Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients. Transfusion 59(5):1698\u20131705. https:\/\/doi.org\/10.1111\/trf.15227. Epub 20190308. PubMed PMID: 30848512","journal-title":"Transfusion"},{"issue":"5","key":"16_CR51","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bjh.13339","volume":"169","author":"JB Vidler","year":"2015","unstructured":"Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL (2015) Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br J Haematol. 169(5):746\u2013753. Epub 20150305. PubMed PMID: 25753472. https:\/\/doi.org\/10.1111\/bjh.13339","journal-title":"Br J Haematol."},{"issue":"2","key":"16_CR52","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/trf.15010","volume":"59","author":"CL Dean","year":"2019","unstructured":"Dean CL, Maier CL, Roback JD, Stowell SR (2019) Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease. Transfusion 59(2):448\u2013453. https:\/\/doi.org\/10.1111\/trf.15010. Epub 20181109. PubMed PMID: 30412270","journal-title":"Transfusion"},{"issue":"6","key":"16_CR53","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/trf.14610","volume":"58","author":"MEM Yee","year":"2018","unstructured":"Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T et al (2018) Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy. Transfusion. 58(6):1363\u20131371. https:\/\/doi.org\/10.1111\/trf.14610. Epub 20180417. PubMed PMID: 29664198; PubMed Central PMCID: PMCPMC6021219","journal-title":"Transfusion."},{"issue":"5","key":"16_CR54","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/trf.17800","volume":"64","author":"MEM Yee","year":"2024","unstructured":"Yee MEM, Zerra PE, McCoy JW, Covington ML, Stowell SR, Joiner CH et al (2024) Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance. Transfusion 64(5):800\u2013807. https:\/\/doi.org\/10.1111\/trf.17800. Epub 20240320. PubMed PMID: 38506450; PubMed Central PMCID: PMCPMC11088511","journal-title":"Transfusion"},{"issue":"1","key":"16_CR55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/blood-2006-03-007153","volume":"109","author":"SR Stowell","year":"2007","unstructured":"Stowell SR, Karmakar S, Stowell CJ, Dias-Baruffi M, McEver RP, Cummings RD (2007) Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood. 109(1):219\u2013227. https:\/\/doi.org\/10.1182\/blood-2006-03-007153. Epub 20060829. PubMed PMID: 16940423; PubMed Central PMCID: PMCPMC1785076","journal-title":"Blood."},{"issue":"15","key":"16_CR56","doi-asserted-by":"publisher","first-page":"10109","DOI":"10.1074\/jbc.M709545200","volume":"283","author":"SR Stowell","year":"2008","unstructured":"Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, Leffler H et al (2008) Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem. 283(15):10109\u201310123. https:\/\/doi.org\/10.1074\/jbc.M709545200. Epub 20080123. PubMed PMID: 18216021; PubMed Central PMCID: PMCPMC2442294","journal-title":"J Biol Chem."},{"issue":"6","key":"16_CR57","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/trf.17857","volume":"64","author":"MEM Yee","year":"2024","unstructured":"Yee MEM, Covington ML, Zerra PE, McCoy JW, Easley KA, Joiner CH et al (2024) Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease. Transfusion. 64(6):1109\u20131115. https:\/\/doi.org\/10.1111\/trf.17857. Epub 20240501. PubMed PMID: 38693059; PubMed Central PMCID: PMCPMC11144116","journal-title":"Transfusion."}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:49:59Z","timestamp":1788302999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":57,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}